NEWS | BEAM Alliance


Motif Bio to Present Iclaprim Data at ECCMID 2019

Motif Bio plc (AIM/NASDAQ: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, announced today that four iclaprim abstracts have been accepted for presentation at the upcoming 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2019) to be held in Amsterdam, The Netherlands, April 13-16, 2019.ECCMID brings together leading experts in the infectious diseases, infection control and clinical microbiology sector to present and discuss the latest results.

Details for each presentation and poster are noted below, including links to the related abstracts, which are available at

Full PR available here